Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Jun;28(3):818–823. doi: 10.1128/iai.28.3.818-823.1980

Mitogenicity of a lipid-deficient lipoprotein from a mutant Escherichia coli strain.

W G Bessler, E Simon, H Rotering
PMCID: PMC551023  PMID: 6995322

Abstract

From the mutant bacterial strain Escherichia coli JE5511 lpp lpm, muropeptide-containing and muropeptide-free lipoproteins were prepared. By gas chromatography and by infrared spectroscopy we showed that the products were deficient in the two ester-bound N-terminal fatty acids, but still carried the amide-linked fatty acid. Mutant lipoproteins were tested for mitogenicity in lipopolysaccharide nonresponder C3H/HeJ mice by incorporation of [3H]thymidine and [3H]uridine and by hemolytic plaque assays for immunoglobulin-secreting plasma cells. Our results showed that the mutant lipoproteins still exhibited marked mitogenicity toward mouse B-lymphocytes, although the activity of the products was reduced in comparison to the wild-type lipoprotein. Thus, the presence of one fatty acid in the N-terminal part of lipoprotein is sufficient to bring about mitogenicity.

Full text

PDF
818

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson J., Melchers F., Galanos C., Lüderitz O. The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med. 1973 Apr 1;137(4):943–953. doi: 10.1084/jem.137.4.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bessler W. G., Henning U. Protein I and protein II from the outer membrane of Escherichia coli are mouse B-lymphocyte mitogens. Z Immunitatsforsch Immunobiol. 1979 Jun;155(5):387–398. [PubMed] [Google Scholar]
  3. Bessler W. G., Ottenbreit B. P. Studies on the mitogenic principle of the lipoprotein from the outer membrane of Escherichia coli. Biochem Biophys Res Commun. 1976 May 23;76(2):239–246. doi: 10.1016/0006-291x(77)90717-3. [DOI] [PubMed] [Google Scholar]
  4. Bessler W., Resch K., Hancock E., Hantke K. Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli. Z Immunitatsforsch Immunobiol. 1977 Apr;153(1):11–22. [PubMed] [Google Scholar]
  5. Braun V. Covalent lipoprotein from the outer membrane of Escherichia coli. Biochim Biophys Acta. 1975 Oct 31;415(3):335–377. doi: 10.1016/0304-4157(75)90013-1. [DOI] [PubMed] [Google Scholar]
  6. Braun V., Rotering H., Ohms J. P., Hagenmaier H. Conformational studies on murein-lipoprotein from the outer membrane of Escherichia coli. Eur J Biochem. 1976 Nov 15;70(2):601–610. doi: 10.1111/j.1432-1033.1976.tb11051.x. [DOI] [PubMed] [Google Scholar]
  7. Forni L., Coutinho A. An antiserum which recognizes lipopolysaccharide-reactive B cells in the mouse. Eur J Immunol. 1978 Jan;8(1):56–62. doi: 10.1002/eji.1830080112. [DOI] [PubMed] [Google Scholar]
  8. Gronowicz E., Coutinho A., Melchers F. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol. 1976 Aug;6(8):588–590. doi: 10.1002/eji.1830060812. [DOI] [PubMed] [Google Scholar]
  9. Hantke K., Braun V. Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. Eur J Biochem. 1973 Apr;34(2):284–296. doi: 10.1111/j.1432-1033.1973.tb02757.x. [DOI] [PubMed] [Google Scholar]
  10. Inoyye S., Takeishi K., Lee N., DeMartini M., Hirashima A., Inouye M. Lipoprotein from the outer membrane of Escherichia coli: purification, paracrystallization, and some properties of its free form. J Bacteriol. 1976 Jul;127(1):555–563. doi: 10.1128/jb.127.1.555-563.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Melchers F., Braun V., Galanos C. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med. 1975 Aug 1;142(2):473–482. doi: 10.1084/jem.142.2.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rosenstreich D. L., Asselineau J., Mergenhagen S. E., Nowotny A. A synthetic glycolipid with B-cell mitogenic activity. J Exp Med. 1974 Nov 1;140(5):1404–1409. doi: 10.1084/jem.140.5.1404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rotering H., Braun V. Lipid deficiency in a lipoprotein mutant of Escherichia coli. FEBS Lett. 1977 Nov 1;83(1):41–44. doi: 10.1016/0014-5793(77)80637-6. [DOI] [PubMed] [Google Scholar]
  14. Sultzer B. M., Nilsson B. S. PPD tuberculin--a B-cell mitogen. Nat New Biol. 1972 Dec 13;240(102):198–200. doi: 10.1038/newbio240198a0. [DOI] [PubMed] [Google Scholar]
  15. Suzuki H., Nishimura Y., Iketani H., Campisi J., Hirashima A. Novel mutation that causes a structural change in a lipoprotein in the outer membrane of Escherichia coli. J Bacteriol. 1976 Sep;127(3):1494–1501. doi: 10.1128/jb.127.3.1494-1501.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tanford C., Reynolds J. A. Characterization of membrane proteins in detergent solutions. Biochim Biophys Acta. 1976 Oct 26;457(2):133–170. doi: 10.1016/0304-4157(76)90009-5. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES